Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(12):806-807; doi:10.1093/jnci/djj269
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ross, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

NEWS

Circadian Rhythms Play Role in Cancer Research

Karen Ross

The first 10% of the full text of this article appears below.

Over the years, studies have established that circadian clocks, the internal timekeepers that run many biological processes on a near 24-hour schedule, are associated in some way with tumor growth. What's not known is precisely how the relationship works. But now researchers are uncovering some of the clock's key cancer-related components and beginning to envision a time when manipulating or taking advantage of these internal mechanisms could play a role in treating or even preventing cancer.

"We are just learning which components of the circadian timing system are essential in [tumor development and progression]", says Francis Lévi, M.D., Ph.D., of the Institut National de la Santé et de la Recherche Medicale in Villejuif, France.


Figure Removed (Available Only in the Full Text)
View larger version (141K):
[in this window]
[in a new window]
 
Francis Lévi

 
We have "a long way to go to identify specific pathways that are controlled by the circadian clock," says Marina Antoch, Ph.D., of the Lerner Research Institute in Cleveland, "but . . . [Full Text of this Article]

Chronotherapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol Cancer ResHome page
A. E. Hoffman, T. Zheng, Y. Ba, and Y. Zhu
The Circadian Gene NPAS2, a Putative Tumor Suppressor, Is Involved in DNA Damage Response
Mol. Cancer Res., September 1, 2008; 6(9): 1461 - 1468.
[Abstract] [Full Text] [PDF]